Atyr Pharma Inc (ATYR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ATYR Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Atyr Pharma Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent16.16
Available-for-sale Securities, Debt Securities, Current MA41.26
Cash & Short-term Investments57.00
Other Receivables, Net, Current0.43
Prepaid Expense, Current AS0.52
Total Current Assets58.36
Equipment/Property/Plant Net4.13
Other Assets, Noncurrent7.34
Restricted Cash Noncurrent2.24
Operating Lease Right Of Use Asset5.52
Total Assets69.83
Liabilities
Accounts Payable, Current AC3.24
Accrued Liabilities, Current AC6.69
Other Liabilities, Current1.46
Total Current Liabilities11.40
Total Long-term Debt0.00
Other liabilities, Noncurrent9.64
Operating Lease Liability Current0.84
Operating Lease Liability Noncurrent10.31
Total Liabilities21.04
Stockholders' Equity
Common Stock Value0.10
Additional Paid In Capital Common Stock676.02
Retained Earnings / Accumulated Deficit-627.26
Accumulated Other Comprehensive Income-0.07
Other Equity-0.07
Common Stockholder's Equity48.98
Non-controlling interests & other-0.19
Total Stockholder's Equity48.79
Liabilities & Stockholder's Equity69.83
4 historic quarters locked

Sign in to unlock the full Atyr Pharma Inc balance sheet history.

About Atyr Pharma Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001339970-26-000053

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.